Biotech Readout
Subscribe
Sign in
Home
Frontiers
History
Acquisitions
Weekly
Archive
About
Weekly Readout
Latest
Top
Discussions
Biotechs post wins in menopause hot flashes, anxiety disorder, polycythemia vera, and more
Weekly Readout #18: Week ending August 14, 2026
Aug 14
•
Céline
1
1
Surprise approvals of Replimune's RP1 & Moderna's flu vaccine, orexin unlocks narcolepsy, and more
Weekly Readout #17: Week ending August 7, 2026
Aug 7
•
Céline
1
Obesity drug treats alcoholism, a China-originated drug pursues $30 billion market, and more
Weekly Readout #16: Week ending July 31, 2026
Jul 31
•
Céline
1
1
GSK-Nuvalent buyout bears fruit, diabetic obesity drug raises the bar, and more
Weekly Readout #15: Week ending July 24, 2026
Jul 24
•
Céline
1
Approvals for cholesterol-lowering and breast cancer, another tau attempt in Alzheimer's, and more
Weekly Readout #14: Week ending July 17, 2026
Jul 17
•
Céline
1
First positive Phase 3's for B7-H3 in cancer and psilocybin in depression, and more
Weekly Readout #13: Week ending July 10, 2026
Jul 10
•
Céline
2
1
Abivax addresses safety, first Treg approval, and more
Weekly Readout #12: Week ending July 3, 2026
Jul 3
•
Céline
1
China achieves world's first CAR-T approval for solid tumors, green shoots in neuropsych, and more
Weekly Readout #11: Week ending June 26, 2026
Jun 26
•
Céline
1
First approval in recently diagnosed T1D, gene therapy rewrites HAE, and more
Weekly Readout #10: Week ending June 19, 2026
Jun 19
•
Céline
1
3
ADA 2026
Summer's hottest obesity & diabetes conference
Jun 12
•
Céline
1
EULAR 2026
Reviewing innovation from Europe's largest immunology conference
Jun 7
•
Céline
1
ASCO 2026 Awards
Major survival wins in pancreatic, breast, and skin cancer
Jun 5
•
Céline
1
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
